Suppr超能文献

美国国立卫生研究院-美国退休人员协会饮食与健康研究中多种维生素的使用与前列腺癌风险

Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.

作者信息

Lawson Karla A, Wright Margaret E, Subar Amy, Mouw Traci, Hollenbeck Albert, Schatzkin Arthur, Leitzmann Michael F

机构信息

Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.

出版信息

J Natl Cancer Inst. 2007 May 16;99(10):754-64. doi: 10.1093/jnci/djk177.

Abstract

BACKGROUND

Multivitamin supplements are used by millions of Americans because of their potential health benefits, but the relationship between multivitamin use and prostate cancer is unclear.

METHODS

We prospectively investigated the association between multivitamin use and risk of prostate cancer (localized, advanced, and fatal) in 295,344 men enrolled in the National Institutes of Health (NIH)-AARP Diet and Health Study who were cancer free at enrollment in 1995 and 1996. During 5 years of follow-up, 10,241 participants were diagnosed with incident prostate cancer, including 8765 localized and 1476 advanced cancers. In a separate mortality analysis with 6 years of follow-up, 179 cases of fatal prostate cancer were ascertained. Multivitamin use was assessed at baseline as part of a self-administered, mailed food-frequency questionnaire. Relative risks (RRs) and 95% confidence intervals (CIs) were calculated by use of Cox proportional hazards regression, adjusted for established or suspected prostate cancer risk factors.

RESULTS

No association was observed between multivitamin use and risk of localized prostate cancer. However, we found an increased risk of advanced and fatal prostate cancers (RR = 1.32, 95% CI = 1.04 to 1.67 and RR = 1.98, 95% CI = 1.07 to 3.66, respectively) among men reporting excessive use of multivitamins (more than seven times per week) when compared with never users. The incidence rates per 100,000 person-years for advanced and fatal prostate cancers for those who took a multivitamin more than seven times per week were 143.8 and 18.9, respectively, compared with 113.4 and 11.4 in never users. The positive associations with excessive multivitamin use were strongest in men with a family history of prostate cancer or who took individual micronutrient supplements, including selenium, beta-carotene, or zinc.

CONCLUSION

These results suggest that regular multivitamin use is not associated with the risk of early or localized prostate cancer. The possibility that men taking high levels of multivitamins along with other supplements have increased risk of advanced and fatal prostate cancers is of concern and merits further evaluation.

摘要

背景

数百万美国人服用多种维生素补充剂,因其可能对健康有益,但多种维生素的使用与前列腺癌之间的关系尚不清楚。

方法

我们对参加美国国立卫生研究院(NIH)-美国退休人员协会饮食与健康研究的295344名男性进行了前瞻性调查,研究多种维生素的使用与前列腺癌(局限性、晚期和致命性)风险之间的关联。这些男性在1995年和1996年入组时均无癌症。在5年的随访期间,10241名参与者被诊断患有前列腺癌新发病例,包括8765例局限性癌症和1476例晚期癌症。在一项为期6年随访的单独死亡率分析中,确定了179例致命性前列腺癌病例。多种维生素的使用在基线时通过一份自行填写并邮寄的食物频率问卷进行评估。使用Cox比例风险回归计算相对风险(RRs)和95%置信区间(CIs),并对已确定或疑似的前列腺癌风险因素进行调整。

结果

未观察到多种维生素的使用与局限性前列腺癌风险之间存在关联。然而,我们发现,与从不服用多种维生素的男性相比,报告过量使用多种维生素(每周超过7次)的男性患晚期和致命性前列腺癌的风险增加(RR分别为1.32,95%CI为1.04至1.67;RR为1.98,95%CI为1.07至3.66)。每周服用多种维生素超过7次的人群中,晚期和致命性前列腺癌的发病率分别为每10万人年143.8例和18.9例,而从不服用者分别为113.4例和11.4例。过量使用多种维生素与前列腺癌的正相关在有前列腺癌家族史或服用包括硒、β-胡萝卜素或锌在内的单一微量营养素补充剂的男性中最为明显。

结论

这些结果表明,定期服用多种维生素与早期或局限性前列腺癌风险无关。大量服用多种维生素及其他补充剂的男性患晚期和致命性前列腺癌风险增加,这一可能性令人担忧且值得进一步评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验